NSPR InspireMD, Inc. Stock Quote

NSPR [NASD]

Index	-	P/E	-	EPS (ttm)	-9.45	Insider Own	2.10%	Shs Outstand	7.80M	Perf Week	8.65%
Market Cap	18.46M	Forward P/E	-	EPS next Y	-2.69	Insider Trans	110.07%	Shs Float	7.56M	Perf Month	-21.12%
Income	-14.90M	PEG	-	EPS next Q	-0.73	Inst Own	2.00%	Short Float	1.08%	Perf Quarter	-8.13%
Sales	4.50M	P/S	4.10	EPS this Y	70.90%	Inst Trans	-2.97%	Short Ratio	3.42	Perf Half Y	-36.34%
Book/sh	4.30	P/B	0.53	EPS next Y	-33.90%	ROA	-33.10%	Target Price	5.25	Perf Year	-58.15%
Cash/sh	4.16	P/C	0.54	EPS next 5Y	-	ROE	-37.80%	52W Range	1.91 - 6.82	Perf YTD	-25.17%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-44.10%	52W High	-66.86%	Beta	1.41
Dividend %	-	Quick Ratio	8.30	Sales past 5Y	18.90%	Gross Margin	16.80%	52W Low	18.32%	ATR	0.21
Employees	52	Current Ratio	8.50	Sales Q/Q	600.00%	Oper. Margin	-	RSI (14)	40.18	Volatility	7.73% 10.14%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	65.10%	Profit Margin	-	Rel Volume	1.37	Prev Close	2.26
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 10 BMO	Payout	-	Avg Volume	23.93K	Price	2.26
Recom	2.00	SMA20	-2.50%	SMA50	-17.14%	SMA200	-32.38%	Volume	32,694	Change	0.00%

Jan-07-16

Initiated

Rodman & Renshaw

Buy

Mar-13-15

Downgrade

Oppenheimer

Outperform → Perform

Nov-26-13

Initiated

Oppenheimer

Outperform

May-10-22 07:30AM	InspireMD Reports First Quarter 2022 Financial Results and Business Update GlobeNewswire
Apr-28-22 07:30AM	InspireMD to Report First Quarter 2022 Financial Results on May 10, 2022 and Provide Corporate Business Update GlobeNewswire
Mar-16-22 04:05PM	InspireMD to Host Key Opinion Leader Event on Carotid Artery Disease Management and Stroke Prevention in combination with the CGuard Stent Platform & MicroNet Portfolio GlobeNewswire
Mar-08-22 07:30AM	InspireMD Reports Fourth Quarter and Year-End 2021 Financial Results GlobeNewswire
Feb-28-22 07:00AM	InspireMD Announces the Inclusion of its CGuard Carotid Stent in CREST-2 Trial Following FDA Approval of the Investigational Device Exemption Supplement Application GlobeNewswire
Feb-22-22 04:30PM	InspireMD to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022 and Provide Corporate Business Update GlobeNewswire
Feb-15-22 08:00AM	InspireMD Announces Adnan Siddiqui, MD, PhD as a Member of its Scientific Advisory Board and Strategic Advisor GlobeNewswire
Jan-27-22 08:00AM	InspireMD to Present at the 16th Biennial Scientific Meeting of the International Andreas Gruentzig Society (IAGS) GlobeNewswire
Jan-18-22 08:11AM	InspireMD Announces Live Case Broadcast at ISET 2022 Conference Following the Supplement Approval by the FDA Regarding its Pivotal C-Guardians Trial GlobeNewswire
Nov-22-21 06:02AM	We're Keeping An Eye On InspireMD's (NASDAQ:NSPR) Cash Burn Rate Simply Wall St.
Nov-09-21 07:30AM	InspireMD Reports Third Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire
Nov-03-21 04:05PM	InspireMD Announces Publication of 12-Month Results of CGuard EPS SIBERIA Trial in Journals of the American College of Cardiology: Cardiovascular Interventions GlobeNewswire
Oct-26-21 08:30AM	InspireMD to Report Third Quarter 2021 Financial Results on November 9, 2021 and Provide Corporate Business Update GlobeNewswire
Oct-13-21 08:30AM	InspireMD Receives Reimbursement Approval for CGuard Embolic Prevention System from the French National Authority for Health GlobeNewswire +5.10%
Aug-10-21 07:00AM	InspireMD Announces Strong Second Quarter 2021 Financial Results GlobeNewswire
Aug-04-21 08:30AM	InspireMD to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021, and Provide Corporate Update GlobeNewswire
Jul-23-21 08:30AM	InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS GlobeNewswire -6.68%
Jun-02-21 08:04AM	InspireMD to Present at the LD Micro Virtual Invitational Conference on June 9, 2021 GlobeNewswire
May-27-21 08:00AM	InspireMD Announces Warrants Exchange Listing Transfer to Nasdaq GlobeNewswire
May-24-21 05:07AM	Will InspireMD (NASDAQ:NSPR) Spend Its Cash Wisely? Simply Wall St. -7.59%
May-21-21 08:30AM	InspireMD Commences Trading on Nasdaq-CM GlobeNewswire +5.88%
May-14-21 06:00AM	InspireMD to Participate at the Investor Summit Conference and Present to Investors on May 17, 2021 GlobeNewswire
May-12-21 06:00AM	InspireMD Announces Appointment of Katie Arnold to Board of Directors GlobeNewswire
May-11-21 06:30AM	InspireMD, Inc. to Host Earnings Call ACCESSWIRE
06:00AM	InspireMD Announces First Quarter 2021 Financial Results GlobeNewswire
May-10-21 04:05PM	InspireMD Announces Stock Exchange Listing Transfer to Nasdaq GlobeNewswire -5.95%
May-06-21 06:00AM	InspireMD to Participate at the Benzinga Global Small Cap Conference and Present to Investors on May 14, 2021 GlobeNewswire -10.29%
May-04-21 04:15PM	InspireMD to Report First Quarter 2021 Financial Results on Tuesday, May 11, 2021 and Provide Corporate Update GlobeNewswire
Apr-29-21 06:00AM	InspireMD Appoints Acclaimed Interventional Cardiologist Kenneth Rosenfield, MD as Chair of its Newly Formed Scientific Advisory Board GlobeNewswire -6.14%
Apr-19-21 06:00AM	InspireMD Provides Corporate Update for Shareholders GlobeNewswire +11.54%
Apr-15-21 07:49AM	The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split Benzinga -22.35%
Apr-14-21 04:05PM	InspireMD Announces 1-for-15 Reverse Stock Split GlobeNewswire
Mar-22-21 07:53AM	InspireMD CEO Marvin Slosman Issues Letter to Fellow Stockholders Urging Support of the Companys Plans to List its Common Stock on Nasdaq at the Upcoming Special Meeting of Stockholders GlobeNewswire -5.34%
Mar-09-21 06:30AM	InspireMD Announces Fourth Quarter and Year-End 2020 Financial Results GlobeNewswire
05:30AM	InspireMD, Inc. to Host Earnings Call ACCESSWIRE
Mar-08-21 10:11AM	Preview: InspireMD's Earnings Benzinga +8.43%
Mar-02-21 06:00AM	InspireMD to Report Fourth Quarter and Year-End 2020 Financial Results on Tuesday, March 9, 2021 and Provide Corporate Update GlobeNewswire
Feb-24-21 06:00AM	InspireMD Engages Hart Clinical Consultants to Conduct Clinical Trial for CGuard Carotid Stent System in the United States GlobeNewswire +9.57%
Feb-09-21 06:00AM	InspireMD Appoints Leading Interventional Cardiologist Chris Metzger, M.D. as Principal Investigator for CGuard Registration Trial in the United States GlobeNewswire -6.56%
Feb-08-21 04:05PM	InspireMD Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option GlobeNewswire +48.78%
Feb-04-21 08:30AM	InspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering GlobeNewswire -6.60%
Feb-03-21 08:32AM	InspireMD Secures Partner for Intended Registration and Distribution of CGuard EPS in Mainland China GlobeNewswire +7.33%
Jan-26-21 06:30AM	InspireMDs CGuard Featured in Multiple Presentations, Including a Live Case Demonstration During the Leipzig Interventional Congress January 25-29, 2021 GlobeNewswire
Nov-29-20 02:33PM	Is InspireMD Inc (NSPR) A Good Buy Now? Insider Monkey
Nov-11-20 07:14AM	InspireMD, Inc. (NYSEMKT:NSPR) Just Reported, And Analysts Assigned A US$0.85 Price Target Simply Wall St.
Nov-09-20 06:30AM	InspireMD Announces Third Quarter 2020 Financial Results GlobeNewswire
Nov-03-20 07:53AM	UPDATE - InspireMD, Inc. Appoints Andrea Tommasoli Senior Vice President of Global Sales and Marketing and Reports Inducement Grants Under NYSE American Company Guide §711(a) GlobeNewswire
06:30AM	InspireMD, Inc. Appoints Andrea Tommasoli Senior Vice President of Global Sales and Marketing and Reports Inducement Grants Under NYSE American Company Guide §711(a) GlobeNewswire
Nov-02-20 06:30AM	InspireMD to Report Third Quarter 2020 Financial Results on Monday, November 9, 2020 and Provide Corporate Update GlobeNewswire
Oct-13-20 06:30AM	InspireMD Announces Renowned Interventional Cardiologist Gary S. Roubin, M.D., Ph.D., to Join Board of Directors GlobeNewswire
Oct-06-20 06:30AM	InspireMD, Inc. Appoints Patrick Jamnik as Vice President of Business Development and Strategic Initiatives and Reports Inducement Grants Under NYSE American Company Guide §711(a) GlobeNewswire
Sep-10-20 06:30AM	InspireMD Announces Christina Brennan, M.D., MBA to Serve in Advisory Role for Pivotal Study of CGuard Carotid Stent System GlobeNewswire +7.27%
Sep-08-20 06:30AM	InspireMD Announces Approval of Investigational Device Exemption (IDE) for Pivotal Study of CGuard Carotid Stent System GlobeNewswire +9.09%
Sep-03-20 06:30AM	InspireMD Announces the European Society of Cardiology 2020 Best Poster Award for Updated Data from the PARADIGM-EXTEND Study GlobeNewswire
Aug-31-20 05:00PM	(LD Micro) 360 Companies Set to Present this Week ACCESSWIRE -10.95%
Aug-25-20 06:30AM	InspireMD to Present at the LD Micro 500 Virtual Conference on September 3, 2020 GlobeNewswire
Aug-10-20 06:30AM	InspireMD Regains Compliance with NYSE AMERICAN Listing Standards GlobeNewswire
Aug-05-20 06:40AM	InspireMD Announces Second Quarter 2020 Financial Results GlobeNewswire
Jul-29-20 04:05PM	UPDATE: InspireMD to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020 and Provide Corporate Update GlobeNewswire
Jul-28-20 08:30AM	InspireMD to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020 and Provide Corporate Update GlobeNewswire
Jul-23-20 08:00AM	InspireMD Gains Registration Clearance of its CGuard Embolic Prevention System (EPS) in Brazil GlobeNewswire
Jun-25-20 10:00AM	InspireMD Announces Late-Breaking Presentation of Early SIBERIA Clinical Trial Results to be Featured in an e-Course at EuroPCR GlobeNewswire
Jun-12-20 04:55AM	Daveys miraculous nano-cap trade Financial Times -5.36%
Jun-10-20 08:00AM	InspireMD Announces Publication of 12-Month Results of CGuard EPS PARADIGM Trial in EuroIntervention GlobeNewswire +24.38%
Jun-08-20 08:00AM	InspireMD, Inc. Announces Underwriter Exercise of Over-Allotment Option in Full and Closing of $11.5 Million Follow-On Underwritten Public Offering GlobeNewswire
Jun-04-20 05:19PM	Edited Transcript of NSPR earnings conference call or presentation 12-May-20 12:30pm GMT Thomson Reuters StreetEvents +8.67%
Jun-03-20 07:40AM	InspireMD, Inc. Announces Pricing of $10 Million Underwritten Public Offering GlobeNewswire -35.99%
May-12-20 07:00AM	InspireMD Announces First Quarter 2020 Financial Results GlobeNewswire +19.59%
May-05-20 08:00AM	InspireMD to Report First Quarter 2020 Financial Results and Provide Business Update on Tuesday, May 12 GlobeNewswire
Apr-07-20 05:10PM	Edited Transcript of NSPR earnings conference call or presentation 10-Mar-20 12:30pm GMT Thomson Reuters StreetEvents -5.66%
Mar-12-20 09:13AM	InspireMD, Inc. Just Reported Earnings, And Analysts Cut Their Target Price Simply Wall St. -14.58%
Mar-10-20 08:00AM	InspireMD Announces Fourth Quarter and Year-End 2019 Financial Results GlobeNewswire -19.92%
Mar-03-20 08:00AM	InspireMD to Report Fourth Quarter 2019 Financial Results and Provide Business Update on Tuesday, March 10 GlobeNewswire
Jan-29-20 08:00AM	InspireMD Announces Successful Live Clinical Case Transmissions Featuring CGuard EPS at the Leipzig Interventional Course (LINC) 2020 GlobeNewswire -9.22%
Jan-27-20 08:00AM	InspireMDs CGuard Embolic Prevention System to be Prominently Featured in Live Case Transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany GlobeNewswire
Jan-08-20 09:15AM	DexCom (DXCM) Hits Fresh High: Is There Still Room to Run? Zacks
Jan-06-20 08:00AM	InspireMD Announces Strong Preliminary Fourth Quarter 2019 Revenue and Reports Inducement Award Under NYSE American Company Guide §711(a) GlobeNewswire
Dec-19-19 09:59AM	Zacks.com featured highlights include: Civeo, InspireMD, Westport Fuel Systems, Genesco and Radware Zacks
Dec-18-19 05:29AM	5 Stocks With Rising P/E That Won't Let You Down Zacks +11.90%
Dec-10-19 08:00AM	InspireMD Announces Planned Leadership Transition GlobeNewswire
Dec-03-19 11:44PM	Edited Transcript of NSPR earnings conference call or presentation 12-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-26-19 03:42PM	InspireMD (NSPR) Stock Could Skyrocket Over 370%, Says Analyst TipRanks +14.49%
08:00AM	InspireMD Reports Updated Positive CGuard EPS Data Presented at VEITH 2019 GlobeNewswire
Nov-13-19 08:36AM	Is InspireMD, Inc. (NYSEMKT:NSPR) A Volatile Stock? Simply Wall St. -6.68%
Nov-12-19 07:00AM	InspireMD Announces Third Quarter 2019 Financial Results GlobeNewswire -21.05%
Nov-05-19 08:00AM	InspireMD to Report Third Quarter 2019 Financial Results and Provide Business Update on Tuesday, November 12 GlobeNewswire +8.47%
Sep-19-19 09:12PM	InspireMD, Inc. Announces Pricing of $5 Million Underwritten Public Offering GlobeNewswire -29.73%
Sep-09-19 08:05AM	InspireMD Provides Business Update GlobeNewswire +11.58%
08:00AM	InspireMD to Present at the HC Wainwright 21st Annual Global Investment Conference GlobeNewswire
Sep-02-19 08:09PM	Edited Transcript of NSPR earnings conference call or presentation 6-Aug-19 12:00pm GMT Thomson Reuters StreetEvents
Aug-26-19 07:42AM	4 Defensible Healthcare Stocks Gaining While the Market Falls TipRanks -18.77%
Aug-09-19 04:30PM	InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency GlobeNewswire
Aug-06-19 07:00AM	InspireMD Announces Second Quarter 2019 Financial Results GlobeNewswire
Jul-30-19 04:05PM	InspireMD to Report Second Quarter 2019 Financial Results and Provide Business Update on Tuesday, August 6 GlobeNewswire
Jul-29-19 10:34AM	InspireMD (NSPR) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
Jul-11-19 09:58AM	Do Institutions Own InspireMD, Inc. (NYSEMKT:NSPR) Shares? Simply Wall St.
May-16-19 06:10AM	Edited Transcript of NSPR earnings conference call or presentation 14-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-14-19 07:00AM	InspireMD Announces First Quarter 2019 Financial Results GlobeNewswire
May-07-19 08:00AM	InspireMD to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 14 GlobeNewswire
Apr-04-19 06:00AM	InspireMD, Inc. Announces Pricing of $2.4 Million Public Offering of Common Stock GlobeNewswire

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROUBIN GARY S	Director	Dec 28	Buy	3.08	16,393	50,436	128,694	Dec 30 09:00 AM
Stuka Paul	Director	Dec 01	Buy	3.51	12,037	42,288	73,534	Dec 02 06:30 PM
Stuka Paul	Director	Nov 30	Buy	3.55	18,372	65,221	61,497	Nov 30 05:53 PM
Stuka Paul	Director	Nov 29	Buy	3.55	3,177	11,278	43,125	Nov 30 05:53 PM
Stuka Paul	Director	Nov 26	Buy	3.55	1,200	4,260	39,948	Nov 29 04:05 PM
Stuka Paul	Director	Nov 24	Buy	3.55	18,328	65,064	38,748	Nov 26 04:05 PM
Stuka Paul	Director	Nov 23	Buy	3.55	1,204	4,274	20,420	Nov 23 07:34 PM
Stuka Paul	Director	Nov 22	Buy	3.54	19,188	67,874	19,216	Nov 23 07:34 PM
ROUBIN GARY S	Director	Nov 17	Buy	3.86	25,930	99,961	112,301	Nov 18 04:05 PM
ROUBIN GARY S	Director	Aug 25	Buy	4.19	22,249	93,246	69,123	Aug 26 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience